Chinese General Practice ›› 2025, Vol. 28 ›› Issue (18): 2301-2306.DOI: 10.12114/j.issn.1007-9572.2024.0117
• Frontiers of Medicine • Previous Articles
Received:
2024-04-09
Revised:
2024-07-02
Published:
2025-06-20
Online:
2025-04-25
Contact:
LIU Yongchao
通讯作者:
刘永超
作者简介:
作者贡献:
沈明妹负责文章构思、研究资料收集与整理、撰写论文;吕俞娇、张尚博负责研究资料数据复核;周鑫辰、董姝含负责图形绘制及美化;张卓负责参考文献格式的校对及修改;刘永超负责论文修订、文章的质量控制及审校。
基金资助:
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0117
缺血再灌注 | 急性心肌梗死 | 高血压(心肌肥大) | 糖尿病心肌病(心肌纤维化) | |
---|---|---|---|---|
PKC-δ易位 | + | + | ||
CaN/NFAT | + | + | ||
TGF-β1/Smads | + | |||
CaSR/Wnt/β-catenin | + | |||
NF-κB | + | + | + |
Table 1 The signaling pathway mediated by CaSR is involved in the types of myocardial injury diseases
缺血再灌注 | 急性心肌梗死 | 高血压(心肌肥大) | 糖尿病心肌病(心肌纤维化) | |
---|---|---|---|---|
PKC-δ易位 | + | + | ||
CaN/NFAT | + | + | ||
TGF-β1/Smads | + | |||
CaSR/Wnt/β-catenin | + | |||
NF-κB | + | + | + |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
张翥,陶亮亮,刘品刚,等. Wnt/β-catenin抑制剂XAV939对心肌梗死大鼠心肌纤维化的影响[J]. 岭南心血管病杂志,2021,27(2):214-218. DOI:10.3969/j.issn.1007-9688.2021.02.19.
|
[34] |
|
[35] |
|
[36] |
朱烨静,周惠丹,崔小英,等. 钙敏感受体在大剂量瑞芬太尼诱导卵巢癌裸鼠心肌损伤中的作用机制研究[J]. 浙江医学,2021,43(7):696-699,725,后插1. DOI:10.12056/j.issn.1006-2785.2021.43.7.2020-1895.
|
[37] |
|
[38] |
|
[39] |
|
[40] |
|
[41] |
|
[42] |
徐娜,王跃虹,姜晓姝,等. 增加CaSR表达减轻2型糖尿病大鼠心肌纤维化的机制[J]. 哈尔滨医科大学学报,2021,55(1):7-10. DOI:10.3969/j.issn.1000-1905.2021.01.002.
|
[43] |
|
[44] |
|
[45] |
|
[46] |
|
[47] |
|
[48] |
|
[49] |
陈盈宇,王鸥,邢小平. 钙敏感受体拮抗剂(溶钙素)的临床应用[J]. 中华骨质疏松和骨矿盐疾病杂志,2021,14(5):553-559. DOI:10.3969/j.issn.1674-2591.2021.05.016.
|
[1] | ZHU Ziyi, HE Guixin, QIN Weibin, SONG Hui, ZHANG Liwen, TANG Weizhi, YANG Feifei, LIU Lingyun, OUYANG Bin. Research Progress of Mitochondrial Autophagy in Improving Myocardial Fibrosis after Myocardial Infarction and Intervention of Traditional Chinese Medicine [J]. Chinese General Practice, 2025, 28(18): 2294-2300. |
[2] | LI Yong, LI Zhanhu, JIN Bowei, LI Yuan, ZHANG Hongbo, SU Yakun, YAN Xiaoju. Correlation between Serum Complement C1q/Tumor Necrosis Factor-related Protein 5 Levels and the Severity of Coronary Artery Lesions and Myocardial Fibrosis Markers in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2024, 27(27): 3365-3371. |
[3] | National Center of Gerontology, Electrocardiology and Cardiac Function Branch of Chinese Geriatric Society, Imaging Group of Cardiovascular Department, Beijing Medical Association, Chinese Medical and Health Culture Association Cardiovascular Health and Science Sports Branch of China Health Culture Association. Expert Consensus for Management of Myocardial Injury, Myocarditis, and Post-infection Condition with Coronavirus Disease 2019 (Second Edition) [J]. Chinese General Practice, 2023, 26(14): 1692-1702. |
[4] | CHEN Fachao,XU Yinchuan,ZHANG Zhaocai. Recent Advances in the Diagnostic Value of New Biochemical Markers of Sepsis-induced Myocardial Injury [J]. Chinese General Practice, 2021, 24(5): 533-538. |
[5] | LUO Fei,LI Shuren,HAO Xiao,BAI Yuhao,YUAN Kexin,XIE Yuetao. Recent Developments in the Pathogenesis of COVID-19-associated Myocarditis [J]. Chinese General Practice, 2021, 24(20): 2589-2593. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||